Duhamel, Marie http://orcid.org/0000-0002-4006-5605
Drelich, Lauranne
Wisztorski, Maxence http://orcid.org/0000-0003-1320-075X
Aboulouard, Soulaimane http://orcid.org/0000-0002-2045-4785
Gimeno, Jean-Pascal
Ogrinc, Nina http://orcid.org/0000-0002-0773-0095
Devos, Patrick http://orcid.org/0000-0001-7803-9552
Cardon, Tristan http://orcid.org/0000-0003-1751-0528
Weller, Michael http://orcid.org/0000-0002-1748-174X
Escande, Fabienne http://orcid.org/0000-0003-4559-5100
Zairi, Fahed
Maurage, Claude-Alain
Le Rhun, Émilie http://orcid.org/0000-0002-9408-3278
Fournier, Isabelle http://orcid.org/0000-0003-1096-5044
Salzet, Michel http://orcid.org/0000-0003-4318-0817
Article History
Received: 19 April 2022
Accepted: 18 October 2022
First Online: 4 November 2022
Competing interests
: Dr. E.L.R. has received honoraria for lectures or advisory board from Adastra, Bayer, Janssen, Leo Pharma, Pierre Fabre, and Seattle Genetics. Dr. M.W. has received research grants from Apogenix, Merck, Sharp & Dohme, Merck (EMD), Philogen and Quercis, and honoraria for lectures or advisory board participation or consulting from Adastra, Bayer, Bristol Meyer Squibb, Medac, Merck, Sharp & Dohme, Merck (EMD), Nerviano Medical Sciences, Novartis, Orbus, Philogen and y-Mabs. The remaining authors declare no competing interests.